Most Recent

image: A Gut Feeling

A Gut Feeling

By | April 1, 2016

See profilee Hans Clevers discuss his work with stem cells and cancer in the small intestine.

0 Comments

image: Cancer's Vanguard

Cancer's Vanguard

By | April 1, 2016

Exosomes are emerging as key players in metastasis.

0 Comments

image: Cancerous Conduits

Cancerous Conduits

By | April 1, 2016

Metastatic cancer cells use nanotubes to manipulate blood vessels.

0 Comments

image: Contributors

Contributors

By | April 1, 2016

Meet some of the people featured in the April 2016 issue of The Scientist.

0 Comments

image: Guts and Glory

Guts and Glory

By | April 1, 2016

An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.

1 Comment

image: Pulling It All Together

Pulling It All Together

By | April 1, 2016

Systems-biology approaches offer new strategies for finding hard-to-identify drug targets for cancer.

0 Comments

image: Shooting for the Moon

Shooting for the Moon

By | April 1, 2016

Defeating cancer is many times more difficult than planting a flag on our lunar satellite.

4 Comments

image: Tumor Traps

Tumor Traps

By | April 1, 2016

After surgery to remove a tumor, neutrophils recruited to the site spit out sticky webs of DNA that aid cancer recurrence.

0 Comments

image: A Different Way of Doing Things

A Different Way of Doing Things

By | April 1, 2016

Cancer cells exhibit altered metabolic processes that may serve as promising targets for new therapies.

0 Comments

image: Metabolic Reprogramming

Metabolic Reprogramming

By | April 1, 2016

How cancer cells fuel their rapid growth

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech